Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHA:600488)
China · Delayed Price · Currency is CNY 4.270
+0.070 (1.67%)
Feb 4, 2026, 3:00 PM CST
SHA:600488 Revenue
Tianjin Tianyao Pharmaceuticals had revenue of 643.16M CNY in the quarter ending September 30, 2025, a decrease of -16.61%. This brings the company's revenue in the last twelve months to 2.87B, down -18.27% year-over-year. In the year 2024, Tianjin Tianyao Pharmaceuticals had annual revenue of 3.22B, down -15.00%.
Revenue (ttm)
2.87B
Revenue Growth
-18.27%
P/S Ratio
1.60
Revenue / Employee
996.74K
Employees
2,884
Market Cap
4.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.22B | -567.54M | -15.00% |
| Dec 31, 2023 | 3.78B | 93.90M | 2.55% |
| Dec 31, 2022 | 3.69B | -59.73M | -1.59% |
| Dec 31, 2021 | 3.75B | 631.82M | 20.27% |
| Dec 31, 2020 | 3.12B | -209.78M | -6.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jinling Pharmaceutical Company | 3.13B |
| Zhejiang Starry Pharmaceutical | 2.39B |
| Yabao Pharmaceutical Group | 2.27B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.74B |
| Ningbo Menovo Pharmaceutical | 1.54B |
| Zhuhai Rundu Pharmaceutical | 1.19B |
| Tibet Weixinkang Medicine | 1.17B |
| LanZhou Foci Pharmaceutical | 895.75M |